114 filings
8-K
CRSP
CRISPR Therapeutics AG
8 May 24
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
4:15pm
8-K
CRSP
CRISPR Therapeutics AG
21 Feb 24
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
CRSP
CRISPR Therapeutics AG
13 Feb 24
Entry into a Material Definitive Agreement
5:22pm
8-K
CRSP
CRISPR Therapeutics AG
13 Feb 24
Other Events
6:30am
8-K
CRSP
CRISPR Therapeutics AG
16 Jan 24
Other Events
4:11pm
8-K
ozb2jlmc8c5p
19 Dec 23
Departure of Directors or Certain Officers
4:23pm
8-K
fswjuierdhqgfvv3n6g
15 Dec 23
Other Events
8:58am
8-K
btxrs9swx4tp r69n2k
13 Dec 23
Entry into a Material Definitive Agreement
9:22am
8-K
ac8tugd2x yc8mxc2
8 Dec 23
Other Events
1:16pm
8-K
aki381kl1tar8fi
4 Dec 23
Other Events
4:26pm
8-K
us4x9
16 Nov 23
Other Events
7:21am
8-K
wwlc9 6to7869rj
6 Nov 23
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
4:33pm
8-K
14vo6nqyk
7 Sep 23
CRISPR Therapeutics Announces Leadership Transition
8:39am
8-K
przgu
7 Aug 23
Results of Operations and Financial Condition
4:07pm
8-K
kdbnktlb 6631tsb
9 Jun 23
Departure of Directors or Certain Officers
4:29pm
8-K
afn5qwvviqd
9 Jun 23
Regulation FD Disclosure
7:07am
8-K
hvx t8ggti
8 May 23
Results of Operations and Financial Condition
4:06pm
8-K
wk757p5xvzzt7vj5
3 Apr 23
Regulation FD Disclosure
8:10am
8-K
kg2gr 2r50jfd
29 Mar 23
CRISPR Therapeutics Announces Departure of Board Member
8:08am
8-K
zb3zua lvg
27 Mar 23
Entry into a Material Definitive Agreement
8:08am